Nevro Corp (NYSE:NVRO)
$ 5.08 -0.26 (-4.87%) Market Cap: 189.40 Mil Enterprise Value: 157.99 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 44/100

Nevro Corp at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2022 / 01:55PM GMT
Release Date Price: $51.25 (+3.51%)
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst

Okay. We'd like to get started. Good morning, everyone. Welcome to the first day of the Morgan Stanley Healthcare Conference. Very excited to have Nevro with us. Rod MacLeod, CFO; and Julie Dewey, IR.

Before we get started, I will read the disclaimer. For important disclosures, please see Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures.

With that, Rod, Julie, thank you again for being here. Glad to have you.

Questions & Answers

Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst

And kind of consistent with probably what we'll hear across the healthcare conference, I wanted to start with what's going on in the market today. Talk a little bit about your guidance, but really stepping back kind of summer seasonality, what you expected, what you kind of experienced pre-COVID. How has that played out to the extent you can

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot